Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays

Universal CRISPR/Cas12a-associated aptasensor suitable for rapid detection of small proteins with a plate reader

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes

Aptamer-Linked CRISPR/Cas12a-Based Immunoassay

Rapid, multiplexed microfluidic phage display.

Compact CRISPR genetic screens enabled by improved guide RNA library cloning

Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer

Cysteine‐independent CRISPR‐associated protein labeling for presentation and co‐delivery of molecules toward genetic and epigenetic regulations

An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening

An In-Library Ligation Strategy and Its Application in CRISPR/Cas9 Screening of High-Order Grna Combinations.

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

A Novel CRISPR Interference Effector Enabling Functional Gene Characterization with Synthetic Guide RNAs

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Progress of CRISPR-based programmable RNA manipulation and detection.

High-throughput in situ cell electroporation microsystem for parallel delivery of single guide RNAs into mammalian cells

High-content CRISPR screening

CRISPR-induced DNA reorganization for multiplexed nucleic acid detection

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations